DAWN

Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DAWN

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/01	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2025/01/13	22:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2025/01/11	06:06	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/12/13	06:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/21	06:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/20	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/20	06:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/19	06:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/19	06:21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/13	06:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/12	21:49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/05	07:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/11/01	05:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/10/31	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/10/31	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/09/13	05:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/08/29	05:07	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/08/20	06:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/08/20	06:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/08/17	06:23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/08/17	06:17	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/08/06	06:05	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/08/03	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/07/30	20:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/07/30	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/07/25	19:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/07/18	05:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/07/17	05:32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/07/06	07:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DAWN	Day One Biopharmaceuticals Inc
2024/06/18	21:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DAWN	Day One Biopharmaceuticals Inc